Increase in prevalence of chronic diseases, surge in the adoption of strategies by key players, and rise in R&D activities in the radiopharmaceuticals sector drive the growth of the global ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Just a year after it was established by venture capital company Eclipse and the Mayo Clinic, Nucleus RadioPharma has attracted $56 million in a series A investment round that will fund new facilities ...

Recently ANSTO researchers have made progress investigating improved ways to make life-saving radiopharmaceuticals using the fluorine-18 radioisotope so they can be available in more hospitals at ...

As the field of biotechnology advances, the ability to treat previously incurable diseases is becoming more of a reality. And one of the champions that’s gaining a lot of attention in the space is ...

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other pharmaceutical companies have spent some $10 billion on radiopharmaceutical acquisitions and partnerships over the past year. Drugmakers are ...

Recent major investments signal growth in an emerging therapeutic sector. Over the last 20 years there has been a tidal wave of innovation when it comes to the treatment of cancer. Traditional ...

Nuclear medicine was first developed in the 1950s as a cancer treatment before shifting to primarily being used as a diagnostic tool, using tiny amounts of radioactive substances to image different ...

To find out how FDA’s new draft guidance, Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development, may impact the development of radiopharmaceuticals as cancer ...

According to Precedence Research, the radiopharmaceuticals market size has been estimated at USD 7.51 billion in 2025 and is projected to reach approximately USD 14.44 billion by 2034, growing at a ...

Radiation therapy was first used to treat cancer over 100 years ago, with about half of all cancer patients today still receiving it at some point during their treatment. Up until recently, radiation ...

Ben Hargreaves examines what advantages radiopharmaceuticals offer in the treatment of cancer and why there has been interest from big pharma in developing these types of therapies. The article also ...